2007
DOI: 10.1200/jco.2006.10.2392
|View full text |Cite
|
Sign up to set email alerts
|

CNS or Bone Marrow Involvement As Risk Factors for Poor Survival in Post-Transplantation Lymphoproliferative Disorders in Children After Solid Organ Transplantation

Abstract: Stage IV disease is an independent risk factor for poor survival in pediatric PTLD patients. Prospective multicenter trials are needed to delineate additional risk factors and to assess treatment approaches for pediatric PTLD.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

14
98
3
5

Year Published

2010
2010
2023
2023

Publication Types

Select...
3
2
2

Relationship

0
7

Authors

Journals

citations
Cited by 132 publications
(122 citation statements)
references
References 45 publications
14
98
3
5
Order By: Relevance
“…tract (Leblond V et al, 1995). The CNS is involved in up to 30% of cases of PTLD and in many of these the disease is confined to the CNS (Maecker B et al, 2007;Penn I & Porat G, 1995). In this respect, PTLD contrasts with NHL in the general population where only around 1% of cases shows isolated CNS involvement.…”
Section: Clinical Presentationmentioning
confidence: 93%
See 1 more Smart Citation
“…tract (Leblond V et al, 1995). The CNS is involved in up to 30% of cases of PTLD and in many of these the disease is confined to the CNS (Maecker B et al, 2007;Penn I & Porat G, 1995). In this respect, PTLD contrasts with NHL in the general population where only around 1% of cases shows isolated CNS involvement.…”
Section: Clinical Presentationmentioning
confidence: 93%
“…More rarely, solitary lesions were seen in the lung, tonsils and central nervous system (CNS). In particular, CNS involvement, especially in paediatric patients seems to be a risk factor for poor prognosis (Maecker B et al, 2007). In patients presenting with multiple lesions, the lymph nodes and liver were most commonly affected.…”
Section: Clinical Presentationmentioning
confidence: 99%
“…(Faull et al, 2005;Webber et al, 2006).More recent data suggest that the median time is later, at approximately 3 years after SOT. ( Evens et al, 2010;Ghobrial et al, 2010;Knight et al, 2009;Maecker et al, 2007) This is partly due to an increase in the diagnosis of EBV-unrelated disease. Multiple reports have shown that EBV-unrelated PTLD occurs later after SOT, most commonly after 3 to 5 years.…”
Section: Ebv+ Vs Ebv-mentioning
confidence: 99%
“… Recurrent chromosomal abnormalities have been reported in some series of B-cell PTLD and may portend a worse prognosis. (Chadburn et al, 1997;Djorkic et al, 2006;Maecker et al, 2007;Swerdlow et al, 2008).…”
Section: Pathogenic Mechanism Of Ebvmentioning
confidence: 99%
See 1 more Smart Citation